Friday evening filings are always the most interesting…
Pensare Aquisition Corp. (WRLS) announced this afternoon that the Company’s sponsor will reduce its contributions to the trust account so that the total monthly payment will be no greater than $200,000. To be clear, Pensare still intends to pay $0.033 per Public Share that is not redeemed to the Trust, but they are capping that amount at a maximum of $200,000 per month. So, if more than 6,060,606 Public Shares remain outstanding after redemptions, then the amount paid per share will be reduced proportionately.
As with most changes to terms, and especially when it’s related to an extension vote, there is usually a deliberate reason behind that change. Whether the SPAC chooses to tell you their reasons almost never happens and we are forced to speculate. Which is why it’s so refreshing to see Pensare be so forthright. To wit, Pensare also disclosed in their press release that, “The Company is currently in active discussions with a target company regarding a potential business combination that is anticipated to require an amount of funding less than the current balance of the Trust Account to consummate the business combination.“
Accordingly, Pensare took a page out of Gig1’s playbook and capped the contribution amount. However, the reasons why they are doing that is because they’re in the unfortunate position of having way too much money for their intended acquisition to make sense. This is why it’s always better to go smaller with a SPAC. You can always raise more money at combination if you need it, but you can’t give money back. Or at least you can by forcing redemptions, but that’s not the way you want to do it.
However, the candor is appreciated. It’s not the most ideal situation, but at least Pensare is including investors in their process.
Stay tuned for any further updates.
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...
In June 2025, the SPAC market was marked by a notable rise in meeting delays, with adjournments and postponements playing a central role in extension activity, as sponsors navigated a more cautious market environment. Still, several SPACs secured shareholder approvals, and seven business combinations were completed during the month. At the same time, IPO issuance...
An In-Depth Look at SPAC Activity Through the Second Quarter & First Half 2025 Below is a summary of the first half of 2025 SPAC market. If you’d like a pdf copy, you can access the link HERE. Q2 kicked off in chaos. President Trump’s shifting and often contradictory tariff announcements sent markets reeling, driving...
At the SPAC of Dawn The market is set to be showered with new SPACs today as three more SPACs priced their IPOs overnight, bringing 2025’s total to 66, already surpassing the full-year total of 2024. After hours, Ribbon (NASDAQ:RIBB) also added a new SPAC deal to June’s tally just under the wire, bringing the...
NMP Acquisition Corp. (NASDAQ:NMPAU) announced the pricing of its $100 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “NMPAU”, Tuesday, July 1, 2025. The new SPAC plans to combine with a target company that has a resilient business model with potential to scale up revenue. NMP’s management...